Soon after starting a new biotechnology company, David Li realized he needed to rethink his strategy. Li had been conducting the competitive research biotech entrepreneurs typically undertake before ...

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

On Wednesday the U.S. Department of Commerce announced it would implement new export controls on certain biotechnology equipment, citing national security concerns relating to artificial ...

WASHINGTON, Jan 15 (Reuters) - The U.S. Commerce Department said Wednesday it is imposing new export controls on biotechnology equipment and related technology because of national security ...

At a time when pharma interest in AI capabilities is surging, it is no surprise that a biotech focused on using “emerging AI tools” in drug discovery and development would have such strong backing.

As 2025 begins, emerging biotechnology firms can be sorted into two groups: haves and have-nots. Venture funding rose last year, but a good portion of that money was concentrated into nine-figure ...

CEO Surbhi Sarna's small team at Collate so far includes founding chief architect Jigish Patel and cofounder and CTO Nate Smith. Surbhi Sarna sold her last startup, nVision Medical, for $275 ...

Eli Lil­ly, the most talked-about phar­ma­ceu­ti­cal com­pa­ny in re­cent years, is buy­ing can­cer start­up Scor­pi­on Ther­a­peu­tics about half a year af­ter its ...

CytomX Therapeutics, a once high-flying biotech firm, is laying off 40% of its staff. The cuts include 45 workers in South San Francisco, where the cancer research company is based — it’s ...